Jogarao Gobburu

Professor

University of Maryland

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Jogarao Gobburu is a faculty member at the University of Maryland, Baltimore, USA. His research focuses on pharmacometrics, pharmacokinetics, and the assessment of drug interactions, particularly in pediatric populations. Recent publications include studies on drug dosing optimization in obstructive HCM and acute kidney injury risk factors in children receiving intravenous therapies.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (7)

Andrew Hooker

Professor of Pharmacometrics

Uppsala University

SWEDEN

View details

Shuhui Li

Bristol-Myers Squibb

UNITED STATES

View details

Parmesh Gajjar

Chief Technology Officer

Infex Therapeutics

UNITED KINGDOM

View details

Beth Apsel Winger

UNITED STATES

View details

James E. Polli

UNITED STATES

View details

Mathangi Gopalakrishnan

UNITED STATES

View details

Allison Dunn

Research Assistant Professor

University of Maryland

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jogarao Gobburu

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Exploration of the potential impact of batch‐to‐batch variability on the establishment of pharmacokinetic bioequivalence for inhalation powder drug products

Exposure–Response Modeling and Simulation to Identify Optimal Mavacamten Posology When Coadministered with CYP3A4 and CYP2C19 Inhibitors in Patients with Obstructive HCM

A Large Cohort Study to Identify Risk Factors of Acute Kidney Injury in Pediatric Patients Undergoing Intravenous Vancomycin Therapy

Guiding Dyslipidemia Treatment: A Population Pharmacokinetic–Pharmacodynamic Framework for Obicetrapib

Pharmacokinetics of Briquilimab as a Conditioning Agent for Hematopoietic Stem Cell Transplantation in Patients With Severe Combined Immunodeficiency, Myelodysplastic Syndrome, or Acute Myeloid Leukemia

Pharmacokinetics of Human Plasma‐Derived Antithrombin in Pediatric Patients Supported on Extracorporeal Membrane Oxygenation

Urine Osmolality Is a Potential Marker of Longer-Term Efficacy of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis

A convolution‐based in vitro‐in vivo correlation model for methylphenidate hydrochloride delayed‐release and extended‐release capsule

Establishing the suitability of model‐integrated evidence to demonstrate bioequivalence for long‐acting injectable and implantable drug products: Summary of workshop

Evaluation of acquired antithrombin deficiency in paediatric patients supported on extracorporeal membrane oxygenation

Assessing Pharmacokinetics in Liver Disease: Challenges and Future Considerations for Classification of Hepatic Dysfunction and Use of In Silico Methods

The trajectory of pharmacometrics to support drug licensing and labelling

Comparing Effects of Tolvaptan and Instruction to Increase Water Consumption in ADPKD: Post Hoc Analysis of TEMPO 3:4

Is There a Need for a Dedicated Pharmacokinetic Trial for a Drug in Obese Populations? A Drug Prioritization Decision Tree Framework

Accelerating the Availability of Medications to Pediatric Patients by Optimizing the Use of Extrapolation of Efficacy

Population Pharmacokinetics of Melphalan for Pediatric Patients Undergoing Hematopoietic Cell Transplantation

Characterization of drug–drug interactions on the pharmacokinetic disposition of busulfan in paediatric patients during haematopoietic stem cell transplantation conditioning

Future of pharmacometrics: Predictive healthcare analytics

A prospective, real‐world, clinical pharmacokinetic study to inform lacosamide dosing in critically ill patients undergoing continuous venovenous haemofiltration (PADRE‐02)

Understanding the Role of Pharmacometrics‐Based Clinical Decision Support Systems in Pediatric Patient Management: A Case Study Using Lyv Software

Collaborators (7)

Andrew Hooker

Shuhui Li

Parmesh Gajjar

Beth Apsel Winger

James E. Polli

Mathangi Gopalakrishnan

Allison Dunn

Make your next move.